Managing IVDR Requirements & Country-Specific Submission Processes to Maintain European & RoW Market Access

10:00 am - Tuesday 17th November 2026

  • Navigating IVDR compliance across European countries to protect ongoing market access
  • Addressing country-specific export restrictions in Brazil, China and France to keep global trials moving
  • Balancing regulatory requirements with operational feasibility to avoid costly protocol amendments

Speakers:

Associate Director, Biomarker & Diagnostic Operations
Johnson & Johnson